Inhibition of Apolipoprotein(a) Synthesis by Farnesoid X Receptor and Fibroblast Growth Factor 15/19: A Step Toward Selective Lipoprotein(a) Therapeutics

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.112.245571
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Hepatic Farnesoid X Receptor Protein Level and Circulating Fibroblast Growth Factor 19 Concentration in Children With NAFLD

Liver International
Hepatology
2017English

Benefit of Farnesoid X Receptor Inhibition in Obstructive Cholestasis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Inhibition of Tumor Growth With a Vaccine Based on Xenogeneic Homologous Fibroblast Growth Factor Receptor-1 in Mice

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Finding Fibroblast Growth Factor 19 During Cholestasis: Does X Mark the Spot?

Journal of Hepatology
Hepatology
2018English

Fibroblast Growth Factor Receptor (FGFR)

Science-Business eXchange
2013English

Effect of Nerve Growth Factor and Fibroblast Growth Factor on PC12 Cells: Inhibition by Orthovanadate

Journal of Cell Biology
MedicineCell Biology
1993English

The Effects of Metformin on Fibroblast Growth Factor 19, 21 and Fibroblast Growth Factor Receptor 1 in High-Fat Diet and Streptozotocin Induced Diabetic Rats

Endocrine Journal
EndocrinologyMetabolismDiabetes
2017English

FGFR1 (Fibroblast Growth Factor Receptor 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease

Molecular Pharmacology
Molecular MedicinePharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy